Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patientโs breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
์ข
๋ชฉ ์ฝ๋ INSP
ํ์ฌ ์ด๋ฆInspire Medical Systems Inc
์์ฅ์ผMay 03, 2018
CEOHerbert (Timothy P)
์ง์ ์1246
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃMay 03
์ฃผ์5500 Wayzata Blvd Ste 1600
๋์GOLDEN VALLEY
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX NASDAQ Basic NYSE
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ55416-1237
์ ํ17639575037
์น์ฌ์ดํธhttps://www.inspiresleep.com/
์ข
๋ชฉ ์ฝ๋ INSP
์์ฅ์ผMay 03, 2018
CEOHerbert (Timothy P)